FSRH CEU Statement: New manufacturer/MHRA advice regarding nomegestrol acetate – how does this affect prescribing of Zoely®? (April 2023)

A woman with a systolic BP greater than 160 or diastolic greater than 100 would be a UKMEC 4 for combined hormonal methods but a 2 for the implant or progestogen only pill. Contraception is free on the NHS. Find out where to get contraception and search by postcode to find: A woman with current breast cancer would be a 4 for any hormonal method but it would be a 3 if she had breast cancer in the past.Methods include: all hormonal contraceptives; intrauterine methods; and EC. Health conditions cover lifestyle (age and smoking) as well as medical conditions such as migraine, whether and how long post-natal, history of VTE (venous thrombo-embolism), breast cancer etc. Use of each method in each situation or medical condition is then allocated one of four categories as below. New conditions have been added to reflect population risk changes (bariatric surgery, organ transplant), increasingly recognised conditions (long QT syndrome) and rheumatoid arthritis. the UKMEC categorises all progestogen-only contraceptives and intrauterine contraception as UKMEC 1, which means that there are no restrictions on the use of these methods.

If a contraception is used for a non-contraceptive indication (for example management of heavy menstrual bleeding) the risk/benefit profile and eligibility criteria may differ In addition there are categories for Initiation of a method by a woman with a specific condition and Continuation of a method in a woman who develops a new medical condition. What does all this mean in practice? For women with obesity (BMI categories of >=30-34 kg/m2 and >=35 kg/m2) of all ages, all estrogen containing contraception (i.e. combined hormonal contraception (CHC), including combined oral contraception (COC) containing both ethinylestradiol (EE) and estradiol, patch and ring) FSRH CEU Statement: Response to new study by Meaidi et al (2023) Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs (September 2023) This authoritative, ‘go-to’ reference for clinicians provides contraceptives safely to women across the life course.Drug interactions can potentially cause adverse effects. Health professionals providing hormonal contraception should ask women about their current and previous drug use including prescription, over-the-counter, herbal, recreational drugs, and dietary supplements. Women should be advised to use the most effective methods for them; this may include the additional use of non-hormonal barrier methods when potential drug interactions pose concern